Index Ventures exits X01
According to a blog post on its site, Index Ventures has sold X01 Ltd to Janssen Pharmaceuticals Inc, a Johnson and Johnson subsidiary. No financial terms were disclosed. X01 is a cardiovascular drug startup. To read the announcement, visit here.
20 March 2015•1 min read
